Bolt Biotherapeutics, Inc(NASDAQ:BOLT) 
Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, engages in the discovery, development, and commercialization of pharmaceutical products. The company develops BDC-1001, a human epidermal growth factor receptor 2 (HER2) for the treatment of patients with HER2-expressing solid tum...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 7.80
H 8.00
L 7.00
C 7.20
V 287,969
10EMA 7.20
20EMA 7.20
60EMA 7.20
120EMA 7.20
250EMA 7.20